ICU Medical (ICUI)
(Real Time Quote from BATS)
$111.54 USD
-1.96 (-1.73%)
Updated Jun 14, 2024 10:18 AM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
ICU Medical, Inc. [ICUI]
Reports for Purchase
Showing records 241 - 260 ( 292 total )
Company: ICU Medical, Inc.
Industry: Medical - Products
Healthcare - 2Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: ICU Medical, Inc.
Industry: Medical - Products
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
Raising Target on Potential Takeout Value - Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Good Quarter - Consistent EPS Outlook; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
1Q13 Preview: Expect Rebound in 2Q; Positive FY13 Outlook
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
1Q13 MedTech Preview: ALGN ICUI TRIB CRY CPTS ATEC RTIX SLTM VOLC ATRC (Part 1)
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Healthcare - Notes from the Podium: Med Tech Highlights from the 2013 Roth OC Conference
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
Good 4Q; 1Q Guidance Messy but FY13 Could Be Conservative
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
4Q Preview: Expect Inline Results, Conservative Guidance
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Company: ICU Medical, Inc.
Industry: Medical - Products
Terminating Coverage Due to Analyst Departure.
Provider: COLLIERS SECURITIES
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
PT Up on Rising EPS, Despite Slower Revs; Intro FY14
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Company: ICU Medical, Inc.
Industry: Medical - Products
Company: ICU Medical, Inc.
Industry: Medical - Products
3Q Preview: EPS Needs to Tick Up in 2H12; Stock Has Run
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M